Logo image of SNES

SENESTECH INC (SNES) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SNES - US81720R6045 - Common Stock

2.57 USD
-0.2 (-7.22%)
Last: 12/12/2025, 8:02:34 PM
Fundamental Rating

3

Overall SNES gets a fundamental rating of 3 out of 10. We evaluated SNES against 191 industry peers in the Pharmaceuticals industry. SNES scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SNES is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year SNES has reported negative net income.
In the past year SNES has reported a negative cash flow from operations.
In the past 5 years SNES always reported negative net income.
In the past 5 years SNES always reported negative operating cash flow.
SNES Yearly Net Income VS EBIT VS OCF VS FCFSNES Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -39.89%, SNES is in line with its industry, outperforming 43.98% of the companies in the same industry.
The Return On Equity of SNES (-51.41%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -39.89%
ROE -51.41%
ROIC N/A
ROA(3y)-145.81%
ROA(5y)-129.68%
ROE(3y)-183.8%
ROE(5y)-169.9%
ROIC(3y)N/A
ROIC(5y)N/A
SNES Yearly ROA, ROE, ROICSNES Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K

1.3 Margins

Looking at the Gross Margin, with a value of 63.45%, SNES is in the better half of the industry, outperforming 72.77% of the companies in the same industry.
SNES's Gross Margin has improved in the last couple of years.
SNES does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.57%
GM growth 5Y13.61%
SNES Yearly Profit, Operating, Gross MarginsSNES Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

4

2. Health

2.1 Basic Checks

SNES does not have a ROIC to compare to the WACC, probably because it is not profitable.
SNES has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SNES has more shares outstanding
The debt/assets ratio for SNES is higher compared to a year ago.
SNES Yearly Shares OutstandingSNES Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K 1M
SNES Yearly Total Debt VS Total AssetsSNES Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -11.27, we must say that SNES is in the distress zone and has some risk of bankruptcy.
SNES has a Altman-Z score of -11.27. This is in the lower half of the industry: SNES underperforms 74.87% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that SNES is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, SNES is in line with its industry, outperforming 57.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -11.27
ROIC/WACCN/A
WACC9.28%
SNES Yearly LT Debt VS Equity VS FCFSNES Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

SNES has a Current Ratio of 15.75. This indicates that SNES is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 15.75, SNES belongs to the top of the industry, outperforming 85.86% of the companies in the same industry.
A Quick Ratio of 14.65 indicates that SNES has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 14.65, SNES belongs to the top of the industry, outperforming 84.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.75
Quick Ratio 14.65
SNES Yearly Current Assets VS Current LiabilitesSNES Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

7

3. Growth

3.1 Past

SNES shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.76%, which is quite impressive.
Looking at the last year, SNES shows a very strong growth in Revenue. The Revenue has grown by 39.37%.
SNES shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.70% yearly.
EPS 1Y (TTM)96.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.47%
Revenue 1Y (TTM)39.37%
Revenue growth 3Y45.73%
Revenue growth 5Y67.7%
Sales Q2Q%43.15%

3.2 Future

The Earnings Per Share is expected to grow by 23.98% on average over the next years. This is a very strong growth
Based on estimates for the next years, SNES will show a very strong growth in Revenue. The Revenue will grow by 58.55% on average per year.
EPS Next Y72.07%
EPS Next 2Y37.35%
EPS Next 3Y23.98%
EPS Next 5YN/A
Revenue Next Year24.9%
Revenue Next 2Y48.81%
Revenue Next 3Y58.55%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SNES Yearly Revenue VS EstimatesSNES Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M
SNES Yearly EPS VS EstimatesSNES Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10K -20K -30K -40K -50K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNES. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SNES. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNES Price Earnings VS Forward Price EarningsSNES Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNES Per share dataSNES EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4 -6 -8

4.3 Compensation for Growth

A more expensive valuation may be justified as SNES's earnings are expected to grow with 23.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.35%
EPS Next 3Y23.98%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SNES!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

SENESTECH INC

NASDAQ:SNES (12/12/2025, 8:02:34 PM)

2.57

-0.2 (-7.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-10 2025-11-10/amc
Earnings (Next)03-10 2026-03-10/amc
Inst Owners10.62%
Inst Owner Change385.13%
Ins Owners0%
Ins Owner Change0%
Market Cap13.42M
Revenue(TTM)2.30M
Net Income(TTM)-5.83M
Analysts82.86
Price Target10.2 (296.89%)
Short Float %1.9%
Short Ratio1.07
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)9.09%
EPS NQ rev (3m)9.09%
EPS NY rev (1m)3.53%
EPS NY rev (3m)56.25%
Revenue NQ rev (1m)-11.42%
Revenue NQ rev (3m)-11.42%
Revenue NY rev (1m)-5.13%
Revenue NY rev (3m)-5.13%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.83
P/FCF N/A
P/OCF N/A
P/B 1.18
P/tB 1.18
EV/EBITDA N/A
EPS(TTM)-9.97
EYN/A
EPS(NY)-1.13
Fwd EYN/A
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.02
OCFYN/A
SpS0.44
BVpS2.17
TBVpS2.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -39.89%
ROE -51.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.45%
FCFM N/A
ROA(3y)-145.81%
ROA(5y)-129.68%
ROE(3y)-183.8%
ROE(5y)-169.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.57%
GM growth 5Y13.61%
F-Score5
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.22%
Cap/Sales 6.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.75
Quick Ratio 14.65
Altman-Z -11.27
F-Score5
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)86.22%
Cap/Depr(5y)65.99%
Cap/Sales(3y)11.23%
Cap/Sales(5y)18.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)96.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.47%
EPS Next Y72.07%
EPS Next 2Y37.35%
EPS Next 3Y23.98%
EPS Next 5YN/A
Revenue 1Y (TTM)39.37%
Revenue growth 3Y45.73%
Revenue growth 5Y67.7%
Sales Q2Q%43.15%
Revenue Next Year24.9%
Revenue Next 2Y48.81%
Revenue Next 3Y58.55%
Revenue Next 5YN/A
EBIT growth 1Y12.52%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.1%
EBIT Next 3Y14.16%
EBIT Next 5YN/A
FCF growth 1Y31.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.62%
OCF growth 3YN/A
OCF growth 5YN/A

SENESTECH INC / SNES FAQ

What is the fundamental rating for SNES stock?

ChartMill assigns a fundamental rating of 3 / 10 to SNES.


Can you provide the valuation status for SENESTECH INC?

ChartMill assigns a valuation rating of 1 / 10 to SENESTECH INC (SNES). This can be considered as Overvalued.


Can you provide the profitability details for SENESTECH INC?

SENESTECH INC (SNES) has a profitability rating of 2 / 10.


How financially healthy is SENESTECH INC?

The financial health rating of SENESTECH INC (SNES) is 4 / 10.